8 articles tagged #side-effects.
Foundayo is the first non-peptide GLP-1 pill for weight loss — FDA-approved April 1, 2026. Here's everything you need to know: how it works, clinical trial results, side effects with real percentages, pricing from $149/mo, dosing schedule, and where to get it online.
A practical guide to the most common GLP-1 side effects — nausea, GI issues, hair loss, and more — with evidence-based strategies to manage them and red flags that mean you should call your doctor.
Certain foods can make GLP-1 side effects dramatically worse. Learn which foods to avoid on Ozempic, Wegovy, and Zepbound — plus what to eat instead for better tolerance and results.
The two most prescribed GLP-1 weight loss drugs go head to head — clinical results, pricing, side effects, insurance, and which one is right for you.
The FDA just approved Eli Lilly's Foundayo (orforglipron) — the only GLP-1 weight loss pill with no food, water, or timing restrictions. Here's what it costs, how it works, and how it compares to Wegovy and Zepbound.
Retatrutide achieved 28.7% weight loss in Phase 3 trials — nearly double semaglutide. Here's everything known about Eli Lilly's next-generation triple-agonist, from clinical data to expected approval timeline.
Starting a GLP-1? Here's a realistic week-by-week breakdown of what happens — from the initial consultation through your first dose escalation.
Everything you need to know about GLP-1 receptor agonists — how they work, what the clinical trials show, side effects, eligibility, and how to choose a provider.